Article

A Radio-Genomics Biomarker for Precision Epidermal Growth Factor Receptor Mutation Targeting Therapy in Non-Small Cell Lung Cancer

2025-12-11

Abstract excerpt

<title>Abstract</title> <p> Newer-generation tyrosine kinase inhibitors (TKIs) have shown increasing efficacy in cancers driven by specific mutations, with epidermal growth factor receptor (EGFR) alterations remaining the most common actionable targets in non-small cell lung cancer (NSCLC). Treatment decisions are currently guided by tissue sampling and genetic testing, which are limited by procedural risks, pat...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0dfddf2f-c734-5b68-a571-a75471c9984b
DOI: 10.21203/rs.3.rs-8158721/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A Radio-Genomics Biomarker for Precision Epidermal Growth Factor Receptor Mutation Targeting Therapy in Non-Small Cell Lung CancerDOI 10.21203/rs.3.rs-8158721/v1Read

A radio-genomics biomarker for precision epidermal growth factor receptor mutation targeting therapy in non-small cell lung cancer.Semantic proximity Read

A Novel Radio-Genomics Biomarker for Precision Epidermal Growth Factor Receptor Mutation Targeting Therapy in Non-Small Cell Lung CancerSemantic proximity Read

Radiomic and clinical predictors of epidermal growth factor receptor mutation in stage IA non-small cell lung cancer.Semantic proximity Read

Associations between Radiomics and Genomics in Non-Small Cell Lung Cancer Utilizing Computed Tomography and Next-Generation Sequencing: An Exploratory Study.Semantic proximity Read

Radiomic Analysis and Liquid Biopsy in Preoperative CT of NSCLC : An Explorative ExperienceSemantic proximity Read

Integrated CT-derived radiomics for predicting ctDNA status and prognosis in resectable non-small cell lung cancerSemantic proximity Read

CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer.Semantic proximity Read

Retrospective study on the clinicogenomic characteristics of <i>EGFR</i> mutant and wildtype NSCLCSemantic proximity Read

A Smoking-Independent CT Radiomic Signal Predicts EGFR Mutation in Non-Small-Cell Lung Cancer Under a Pre-Registered, Cross-Validated DesignSemantic proximity Read

Molecular Testing of Lung CancersSemantic proximity Read

Explainable 1-mm Peritumoral CT Radiomics for EGFR Mutation Prediction in Non-small Cell Lung Cancer: A Vietnamese Real-World Cohort Study.Semantic proximity Read

Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphologySemantic proximity Read